![]() |
Open for inclusion |
Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid TumorsCancer type: Lung cancer, Melanoma Phase: I/II Principal Investigator: Nyakas Martha Country: NO Keywords: Norway, Oslo, Advanced solid tumors, BMS-986218, Nivolumab and Ipilimumab Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03110107?term=CA022-001&draw=2&rank=1 |